3rd International Conference on Vaccines Research and Development

The 3rd International Conference on Vaccines Research and Development explores the latest advancements in vaccine development, including emerging technologies, vaccine safety, efficacy, and applications across infectious diseases, autoimmune diseases, cancer, and veterinary vaccinology.

Key Topics

• HIV/AIDS Vaccines
• Next-Generation Vaccines: Advancements and Challenges
• Vaccine Regulation, Safety and Efficacy
• Vaccines for Respiratory Diseases
• Gene Editing for Vaccine Development
• Veterinary Animal and Plant Derived Vaccines
• Infectious & Non-Infectious Diseases
• Advances in Vaccine Development for Autoimmune Diseases: Challenges and Innovations
• Pathogen Profile in the Post-Vaccine Era
• Veterinary Vaccinology
• Public Health Strategies and Policies
• Clinical Trials
• Impact Assessment of Rotavirus Vaccination
• Cancer Vaccines: Innovations and Applications in Veterinary Oncology
• Neuroimmunological Sequelae of Vaccination
• RSV, Influenza, COVID-19
• Immunobiology of Cancer Vaccines
• Identification of Cancer Targets
• Vaccines Misperception and Side Effects
• Vaccines against Neurological Infections
• Comparative Safety of Different Spike-Based Vaccines
• Mucosal, Therapeutic & Ebola Vaccine
• Emerging & Re-Emerging Diseases
• Vaccines for Infectious Diseases
• Identification and Reducing Neurological Risks of Vaccination
• Public Health Policy Role in Vaccine Uptake
• Innovations in Vaccine Design for Enhanced Safety
• Pathogen Profile in the Post-Vaccine Era

Who should Attend

• Researchers and scientists in immunology and microbiology
• Healthcare professionals and clinicians involved in vaccine administration
• Industry leaders in vaccine development and biotechnology
• Public health experts and policymakers
• Veterinarians and researchers in veterinary science
• Experts in infectious disease and autoimmune disease treatment
• Professionals from academic institutions focused on vaccine research
• Editors and staff from scientific journals in microbiology and immunology
• Pharmaceutical and biotech companies focusing on vaccine production
• Scientists involved in cancer immunotherapy and vaccine development